Celularity Inc.
CELU
$2.02
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.28M | 5.74M | 11.43M | 18.13M | 9.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.28M | 5.74M | 11.43M | 18.13M | 9.30M |
| Cost of Revenue | 3.90M | 5.24M | 3.55M | 7.34M | 3.88M |
| Gross Profit | 1.38M | 494.00K | 7.87M | 10.79M | 5.41M |
| SG&A Expenses | 9.31M | 12.63M | 14.26M | 16.06M | 12.65M |
| Depreciation & Amortization | 325.00K | 372.00K | 368.00K | 376.00K | 375.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.13M | 21.60M | 21.91M | 27.61M | 20.82M |
| Operating Income | -12.85M | -15.86M | -10.49M | -9.47M | -11.53M |
| Income Before Tax | -23.08M | -24.52M | -19.75M | -13.29M | -16.10M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -23.08M | -24.52M | -19.75M | -13.29M | -16.10M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.08M | -24.52M | -19.75M | -13.29M | -16.10M |
| EBIT | -12.85M | -15.86M | -10.49M | -9.47M | -11.53M |
| EBITDA | -11.08M | -14.03M | -8.65M | -7.60M | -9.63M |
| EPS Basic | -0.88 | -1.02 | -0.84 | -0.60 | -0.73 |
| Normalized Basic EPS | -0.54 | -0.61 | -0.37 | -0.38 | -0.44 |
| EPS Diluted | -0.88 | -1.02 | -0.84 | -0.60 | -0.73 |
| Normalized Diluted EPS | -0.54 | -0.61 | -0.37 | -0.38 | -0.44 |
| Average Basic Shares Outstanding | 26.35M | 24.02M | 23.53M | 22.29M | 21.98M |
| Average Diluted Shares Outstanding | 26.35M | 24.02M | 23.53M | 22.29M | 21.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |